Skip to main content

TERUMO GLOBAL

Select Region

Show — Select Region Hide — Select Region

- Regions/Countries
  - - Japan
    - United States
      - Terumo Interventional Systems
        
        Terumo Cardiovascular
        
        Terumo Neuro
        
        Terumo Blood and Cell Technologies
        
        Terumo Aortic
        
        Terumo Medical Products
        
        Terumo Medical Corp
        
        Terumo Health Outcomes
    - Canada
  - - Europe
    - Latin America
      - Latin America
        
        Brazil
  - - Asia Pacific
    - Australia
    - Korea
    - Vietnam
    - China
    - India
- Global Business website

About Terumo
About Terumo
Dear Stakeholders
Group Mission
Who We Are
Corporate Governance
Compliance
Regulations and Standards
Procurement Activity
At a Glance
Leadership Team
History
Brand Video "Our Promise"
Terumo's Response to COVID-19
Education and Training
Terumo Ventures
Business Overview
Business Overview
Terumo Interventional Systems
Terumo Neuro
Terumo Cardiovascular / HeartSheet Division
Terumo Aortic
Hospital Care Solutions
Life Care Solutions
Pharmaceutical Solutions
Terumo Blood and Cell Technologies Company (Terumo Blood and Cell Technologies)
Sustainability
Sustainability
Sustainability News
Sustainability at the Terumo Group
GRI Standards Index
Technology
Technology
From Devices to Solutions
Basic Information
Basic Information Top
Research and Development
Production and Supply
Intellectual Property
Terumo Fellows
Stories - Our Technologies
Investors
Investors
Management Policy
Management Policy
Top Management Message
Business Risks
Disclaimer
IR Policy
Financial Highlights
IR Library
IR Library
Financial Statements
Presentations
Consolidated Financial Statements
Terumo Reports
IR Events
Shareholders & Stock
Shareholders Meeting
Stock Information
Shareholder Return
Credit Ratings and Corporate Bond
Analyst Coverage
Articles of Incorporation
Site Quote
IR Inquiries
News
News
July 02, 2025
Corporate
TERUMO ANNOUNCES COMMERCIAL LAUNCH OF THE IMMUCISE™ INTRADERMAL INJECTION SYSTEM
June 27, 2025
Corporate
Terumo Initiates Liquidation Proceedings for Quirem Medical
June 24, 2025
Corporate
Terumo Announces Change of Executive Officers (PDF 75.53 KB)
Global Network
Global Network
Japan
Terumo Medical Pranex
North America
South America
Europe, Middle East and Africa
Greater China
Asia and Pacific

Home
Global Network
Japan
Terumo Corporation

Terumo Corporation

Top

Terumo Corporation 2-44-1 Hatagaya, Shibuya-ku Tokyo, 151-0072, Japan

Footer Menu

Show — Footer Menu Hide — Footer Menu

- Investors
- News
  - - News
    - Press Inquiries
- Global Network

About Terumo
Business Overview
Sustainability
Technology
Investors
News
Global Network

Footer

Show — Footer Hide — Footer

Terms and Conditions of Use
Privacy Policy
Cookie Policy
Cookie Settings
Social Media Policy
Site Map